A protein that shows up in inflammation may signal risk of high blood pressure, researchers report in the first large-scale trial to link the two disorders.
The compound, called C-reactive protein (CRP), has already been implicated in heart disease and stroke. In light of that, some doctors have begun routinely testing patients’ blood for elevated concentrations of the compound.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.